Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.10
-0.20 (-0.29%)
At close: May 28, 2026

TPEX:7871 Statistics

Total Valuation

TPEX:7871 has a market cap or net worth of TWD 9.44 billion. The enterprise value is 8.59 billion.

Market Cap9.44B
Enterprise Value 8.59B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

TPEX:7871 has 134.28 million shares outstanding. The number of shares has increased by 256.69% in one year.

Current Share Class 134.28M
Shares Outstanding 134.28M
Shares Change (YoY) +256.69%
Shares Change (QoQ) +14.41%
Owned by Insiders (%) 8.12%
Owned by Institutions (%) n/a
Float 109.20M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 187.72
PB Ratio 11.40
P/TBV Ratio 11.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.77
EV / Sales 170.92
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -64.88

Financial Position

The company has a current ratio of 10.03, with a Debt / Equity ratio of 0.02.

Current Ratio 10.03
Quick Ratio 9.96
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.14
Interest Coverage -202.63

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -22.77%
Return on Invested Capital (ROIC) -5,001.88%
Return on Capital Employed (ROCE) -23.34%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.09
Inventory Turnover n/a

Taxes

In the past 12 months, TPEX:7871 has paid 14.97 million in taxes.

Income Tax 14.97M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 71.64
200-Day Moving Average n/a
Relative Strength Index (RSI) 49.63
Average Volume (20 Days) 683,431

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7871 had revenue of TWD 50.29 million and -1.11 billion in losses. Loss per share was -14.02.

Revenue50.29M
Gross Profit 49.98M
Operating Income -196.55M
Pretax Income -1.09B
Net Income -1.11B
EBITDA -187.37M
EBIT -196.55M
Loss Per Share -14.02
Full Income Statement

Balance Sheet

The company has 863.36 million in cash and 18.44 million in debt, with a net cash position of 844.93 million or 6.29 per share.

Cash & Cash Equivalents 863.36M
Total Debt 18.44M
Net Cash 844.93M
Net Cash Per Share 6.29
Equity (Book Value) 827.99M
Book Value Per Share 6.25
Working Capital 795.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -131.97 million and capital expenditures -504,000, giving a free cash flow of -132.48 million.

Operating Cash Flow -131.97M
Capital Expenditures -504,000
Depreciation & Amortization 9.18M
Net Borrowing 623.95M
Free Cash Flow -132.48M
FCF Per Share -0.99
Full Cash Flow Statement

Margins

Gross Margin 99.40%
Operating Margin -390.85%
Pretax Margin -2,170.61%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPEX:7871 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -256.69%
Shareholder Yield -256.69%
Earnings Yield -11.72%
FCF Yield -1.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3